Why Is Alivus Life Sciences Ltd. (NSE: ALIVUS.NS) Stock Down Today?
Live update on ALIVUS.NS's movement on the NSE, with key data on price change, volume, technical indicators, sector trends, and analyst sentiment.
Alivus Life Sciences Ltd. (NSE: ALIVUS.NS) Update
Alivus Life Sciences Ltd. (NSE: ALIVUS.NS) Summary
Alivus Life Sciences Ltd. (NSE: ALIVUS.NS) is trading down -1.39% at $1,350.90, reflecting a negative shift in investor sentiment today. The stock opened at $1,365.60 and has moved between $1,331.10 and $1,384.70 so far.
Trading volume is 69573, which is 45% below its average, and the price action suggests selling interest.
Technically, ALIVUS.NS on the NSE is trading above its 50-day moving average of $1,185.83 and above its 200-day moving average of $1,016.55, indicating short-term and long-term strength.
Meyka's AI assigns ALIVUS.NS a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of +5.81% in 1 month ($1,429.32), -33.53% in 1 year ($897.92), and -34.17% in 5 years ($889.35).
See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the NSE.
Stay informed and make better investment decisions.
ALIVUS.NS (NSE) Technical Signals
Trading over 50-day moving average ($1,185.83)
Trading over 200-day moving average ($1,016.55)
Price Forecast
1 Month
$1429.32
1 Year
$897.92
3 Years
$894.07
5 Years
$889.35
Is this change significant?
5-Day:-1.72%
1-Month:+17.94%
3-Month:+27.10%
What's next?
Next earnings date: 7/30/2025